Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ron who wrote (1477)	4/20/2003 3:12:35 AM
From: Icebrg	Read Replies (2) of 3044

>>Wondering what the likelihood is that Velcade will get the go ahead:>> The chances for approval should be say 90 %. Millennium has already started to employ the sales representatives they need to sell the drug. There are no satisfactory treatment options for multiple myeloma today. Not that Velcade will bring cures, but it seems clear that in many cases it may slow the progress of the disease. In other cases it has brought complete remissions to heavily pretreated patients. The FDA cannot really say no unless there are some undisclosed and very negative side-effects. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next